Role of hydrogen sulfide in cognitive deficits: Evidences and mechanisms

被引:30
|
作者
He, Jin-Ting [1 ]
Li, Haiqi [1 ]
Yang, Le [2 ]
Mao, Cui-Ying [3 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Neurol, Changchun 130033, Jilin, Peoples R China
[2] Peoples Hosp Jilin Prov, Dept Endocrinol, Changchun 130031, Jilin, Peoples R China
[3] Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130033, Jilin, Peoples R China
关键词
Memory; Sodium hydrosulfide; Antioxidant; Inflammation; NMDA receptors; Glutamate; ENDOPLASMIC-RETICULUM STRESS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; SODIUM HYDROSULFIDE; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; MEMORY IMPAIRMENT; PROTECTIVE ROLE; NMDA RECEPTORS;
D O I
10.1016/j.ejphar.2019.01.072
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hydrogen sulfide (H2S) is a gaseous molecule and is endogenously produced in the brain by cystathionine betasynthase, 3-mercaptopyruvate-sulfurtransferase, cysteine aminotransferase and cystathionine gamma-lyase. Physiologically, H2S acts as a neuromodulator and regulates synaptic activity of neurons and glia to promote the development of long-term potentiation. A decrease in H2S levels in the brain and plasma has been directly correlated with the degree of severity of Alzheimer disease in patients. A large number of studies have shown a decrease in the H2S levels in experimental models of cognitive dysfunction and exogenous administration of sodium hydrosulfide (NaHS), a H2S donor, has been shown to prevent the development of memory deficits. The beneficial effects of H2S in different models has been ascribed to decrease in neuroinflammation, up-regulation of antioxidant defense, decrease in endoplasmic reticulum (ER) stress, inhibition of phosphatidylinositol 3-kinase (PI3-K)/Akt signaling, inhibition of mitogen activated protein (MAP) kinases, decrease in glutamate and normalization of NMDA receptors, inhibition of matrix metalloproteinases (MMPs), up-regulation of silent information regulator 1 (Sirt 1) and preservation of mitochondrial function. The present review describes the role of H2S in different models of cognitive deficits and human subjects along with possible mechanisms.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 50 条
  • [11] The role of hydrogen sulfide in the retina
    Cornwell, Alex
    Badiei, Alireza
    EXPERIMENTAL EYE RESEARCH, 2023, 234
  • [12] Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
    Tyler A Lesh
    Tara A Niendam
    Michael J Minzenberg
    Cameron S Carter
    Neuropsychopharmacology, 2011, 36 : 316 - 338
  • [13] The Role of Hydrogen Sulfide in Evolution and the Evolution of Hydrogen Sulfide in Metabolism and Signaling
    Olson, Kenneth R.
    Straub, Karl D.
    PHYSIOLOGY, 2016, 31 (01) : 60 - 72
  • [14] Types and mechanisms of cognitive deficits in childhood epilepsy
    Hamed, Sherifa A.
    JOURNAL OF PEDIATRIC EPILEPSY, 2012, 1 (01) : 11 - 26
  • [15] Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
    Lesh, Tyler A.
    Niendam, Tara A.
    Minzenberg, Michael J.
    Carter, Cameron S.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (01) : 316 - 338
  • [16] MECHANISMS OF CHRONIC COGNITIVE DEFICITS AFTER TBI
    McGuire, Jennifer
    DePasquale, Erica
    Asch, Ruth
    Anwar, Fatima
    Koene, Rachel
    McCullumsmith, Robert
    JOURNAL OF NEUROTRAUMA, 2016, 33 (13) : A59 - A59
  • [17] Mechanisms contributing to cognitive deficits in cannabis users
    Mizrahi, Romina
    Watts, Jeremy J.
    Tseng, Kuei Y.
    NEUROPHARMACOLOGY, 2017, 124 : 84 - 88
  • [18] The Role Of Cognitive and Pharmacologic Interventions to Ameliorate Cognitive Deficits
    Gur, Raquel
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 205S - 205S
  • [19] Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions
    Beilharz, Jessica E.
    Maniam, Jayanthi
    Morris, Margaret J.
    NUTRIENTS, 2015, 7 (08) : 6719 - 6738
  • [20] Hydrogen Sulfide in Physiological and Pathological Mechanisms in Brain
    Kumar, Mohit
    Sandhir, Rajat
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (09) : 654 - 670